Recent phase 3 clinical trials have shown that Memantine is an effective way of treatment of both mild and moderate-to-severe Alzheimers disease and possibly vascular dementia (multi-infarct dementia). Memantines method of action involves an uncompetitive, low-affinity, open-channel blocker, it enters the receptor-associated ion channel preferentially when it is excessively open, and, most importantly, its off-rate is relatively fast so that it does not substantially accumulate in the channel to interfere with normal synaptic transmission. Molecular Formula: C12H21N Solubility: Chloroform (Slightly), DMSO (Slightly) Molecular Weight: 179.3 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
179.3
Form:
Supplied as a Clear Colorless Oil to Off-White Waxy Solid
CAS Number:
[19982-08-2]
* VAT and and shipping costs not included. Errors and price changes excepted
